[en] Infections by herpes simplex virus (HSV) types I and II are diverse and quite frequent. After primary infection, the virus establishes a life-long latency in the sensory ganglia and recrudescences may occur at an unpredictable rate. Recurrent labial and genital herpes infections represent the majority of clinical manifestations of HSV infections. Their management is currently well established using evidence-based medicine data. Primary labial herpes is generally not treated with antivirals in otherwise healthy children, although intravenous aciclovir may be offered in severe primary infections, particularly in the immunocompromised patient. The decision whether or not to treat recurrent labial herpes should be evaluated individually and depends on the frequency and severity of relapses, the impairment of the quality of life, and the cost of therapy. Patients with mild disease may benefit from topical therapy, and those with severe and frequent recurrences may be considered for intermittent or long-term oral antiviral therapy. Primary genital herpes is treated with oral or intravenous antivirals, depending on the severity of the infection and associated symptoms. Recurrent genital herpes can be managed with episodic short courses of oral antivirals in patients whose recurrences are moderate to severe and rare, and have a clear prodrome. Patients with >5 episodes/year, severe recurrences or unrecognisable prodromes may be best managed with long-term suppressive antiviral prophylaxis. HSV is also responsible for a variety of other clinical manifestations, including herpetic whitlow, neonatal infection, disseminated and atypical cutaneous infections, traumatic herpes, eczema herpeticum, and HSV-associated erythema multiforme. HSV infection may also represent a complication following cosmetic procedures of the oro-facial region, surgical and dental interventions, sun exposure and burns. Precise treatment guidelines for these HSV infections are not firmly established.
Disciplines :
Dermatologie
Auteur, co-auteur :
Nikkels, Arjen ; Université de Liège - ULiège > Dermatologie
Pierard, Gérald ; Université de Liège - ULiège > Dermatopathologie
Langue du document :
Anglais
Titre :
Treatment of mucocutaneous presentations of herpes simplex virus infections.
Halford W.P., Gebhardt B.M., Carr D.J. (1996) Mechanisms of herpes simplex virus type 1 reactivation. J Virol 70:5051-5060.
Spruance S.L., Overall J.C., Kern E.R. (1977) The natural history of recurrent herpes simplex labialis. N Engl J Med 297:69-75.
Spruance S.L. (1992) The natural history of recurrent oral-facial herpes simplex virus infection. Semin Dermatol 11:200-206.
Higgins C.R., Schofield J.K., Tatnall F.M. (1993) Natural history, management and complications of herpes labialis. J Med Virol 1:22-26.
Shulman J.D., Carpenter W.M., Lewis D.L. (1992) The prevalence of recurrent herpes labialis during an army hot weather exercise. J Public Health Dent 52:198-203.
Rawls W.E., Hammerberg O. (1984) Epidemiology of the herpes simplex viruses. Clin Dermatol 2:29-45.
Amir J., Harel L., Smetana Z. (1997) Treatment of herpes simplex gingivostomatitis with aciclovir in children: A randomised double blind placebo controlled study. BMJ 314:1800-1803.
Young T.B., Rimm E.B., D'Alessio D.J. (1988) Cross-sectional study of recurrent herpes labialis: Prevalence and risk factors. Am J Epidemiol 127:612-625.
Simmons A. (1997) An open-label study conducted to evaluate the efficacy of Betadine cold sore paint. Dermatology 195:85-88.
Embil J.A., Stephens R.G., Manuel F.R. (1975) Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. CMAJ 113:627-630.
Ship I.I., Brightman V.J., Laster L.L. (1967) The patient with recurrent aphthous ulcers and the patient with recurrent herpes labialis: A study of two population samples. JAMA 75:645-654.
Gibson J.J., Hornung C.A., Alexander G.R. (1990) A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Occurrence and determinants of infection. J Infect Dis 162:306-312.
Stuart-Harris C. (1983) The epidemiology and clinical presentation of herpes virus infections. J Antimicrob Chemother 12.
Poland J.M. (1994) Current therapeutic management of recurrent herpes labialis. Gen Dent 42:51-52.
Ficarelli J., Tesini D., Kane J. (1977) Recurrent herpes simplex virus infection, part I: Diagnostic considerations and case report. J Pedod 1:144-159.
Young S.K., Rowe N.H., Buchanan R.A. (1976) A clinical study for the control of facial mucocutaneous herpes virus infections, 1: Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 4:498-507.
Scott D.A., Coulter W.A., Lamey P.J. (1997) Oral shedding of herpes simplex virus type 1: A review. J Oral Pathol Med 26:441-447.
Sawtell N.M. (1998) The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol 72:6888-6892.
Lekstrom-Himes J.A., Pesnicak L., Straus S.E. (1998) The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol 72:2760-2764.
Mindel A. (1991) Is it meaningful to treat patients with recurrent herpetic infections?. Scand J Infect Dis Suppl 80:27-32.
Nikkels A.F., Pièrard G.E. (2002) Current treatments of muco-cutaneous herpes simplex virus infections. Antiinfect Agents 1:83-98.
Ferniano F., Gombos F., Scully C. (2001) Recurrent herpes labialis: Efficacy of topical therapy compared with aciclovir. Oral Dis 7:31-32.
Spruance S.L., Rea T.L., Thoming C. (1997) Penciclovir cream for the treatment of herpes simplex labialis: A randomized, multicenter, double-blind, placebo-controlled trial: Topical penciclovir collaborative group. JAMA 277:1374-1379.
Spruance S.L. (1993) Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol 1:27-32.
Rooney J.F., Bryson Y., Mannix M.L. (1991) Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet 338:1419-1422.
Spruance S.L., Hamill M.L., Hoge W.S. (1988) Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA 260:1597-1599.
Schmidt D.D., Schmidt P.M., Crabtree B.F. (1991) The temporal relationship of psychosocial stress to cellular immunity and herpes labialis recurrences. Fam Med 23:594-599.
Padgett D.A., Sheridan J.F., Dorne J. (1998) Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci U S A 95:7231-7235.
Dalkvist J., Wahlin T.B., Barstch E. (1995) Herpes simplex and mood: A prospective study. Psychosom Med 57:127-137.
Segal A.L., Katcher A.H., Brightman V.J. (1974) Recurrent herpes labialis, recurrent hous ulcers and the menstrual cycle. J Dent Res 53:797-803.
Gonik B., Loo L.S., Bigelow R. (1985) Influence of menstrual cycle variations on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to cells infected with herpes simplex virus. J Reprod Med 30:493-496.
Perna J.J., Mannix M.L., Rooney J.F. (1987) Reactivation of latent herpes simplex virus infection by ultraviolet light: A human model. J Am Acad Dermatol 17:473-478.
Bierman S.M. (1983) A retrospective study of 375 patients with genital herpes simplex infections seen between 1973 and 1980. Cutis 3:548-552.
Brugha R., Keersmaekers K., Renton A. (1997) Genital herpes infection: A review. Int J Epidemiol 26:698-709.
Ashley R.L., Wald A. (1999) Genital herpes: Review of the epidemic and potential use of type specific serology. Clin Microbiol Rev 12:1-8.
Nahmias A., Josey K. (1978) Epidemiology of herpes simplex virus 1 and 2. Viral infections of humans: epidemiology and control , Evans AS, editor. New York: Plenum Medical Book Co.; 253-271.
Catalano P.M., Merritt A.O., Mead P.B. (1991) Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors. Am J Obstet Gynecol 164:1303-1306.
Schomogyi M., Wald A., Corey L. (1998) Herpes simplex virus-2 infection: An emerging disease?. Infect Dis Clin North Am 12:47-61.
Barton I.G., Kinghorn G.R., Najem S. (1982) Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis 58:44-47.
Scoular A., Leask B.G.S., Carrington D. (1990) Changing trends in genital herpes due to herpes simplex virus type 1 in Glasgow, 1985-88. Genitourin Med 66:226.
Ross J.D., Smith I.W., Elton R.A. (1993) The epidemiology of herpes simplex virus types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 69:381-383.
Christie S.N., McCaughey C., McBride M. (1997) Herpes simplex type 1 and genital herpes in Northern Ireland. Int J STD AIDS 8:68-69.
Hashido M., Lee K.F., Nahmias A.J. (1998) An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based in type-specific serological assays. Epidemiol Infect 120:179-186.
Ekwo E., Wong Y.W., Myers M. (1979) Asymptomatic cervicovaginal shedding of herpes simplex virus. Am J Obstet Gynecol 134:102-103.
Kawana T., Kawaguci T., Sakamoto S. (1976) Clinical and virological studies on genital herpes. Lancet 7992:964.
Wald A., Zeh J., Barnum G. (1996) Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 124:8-15.
Bryson Y.J., Dillon M., Lovett M. (1983) Treatment of first episodes of genital herpes simplex virus infection with oral aciclovir: A randomised double-blind controlled trial in normal subjects. N Engl J Med 3308:916-921.
Nilsen A.E., Assen T., Halsos A.M. (1982) Efficacy of oral aciclovir in the treatment of initial and recurrent genital herpes. Lancet 2:571-573.
Mertz G.J., Critchlow C.J., Benedetti J. (1984) Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 252:1147-1151.
Fife K.H., Barbarash R.A., Rudolph T. (1997) Valaciclovir versus aciclovir in the treatment of first-episode genital herpes infection: Results of an international, multicenter, double-blind, randomized clinical trial. Sex Transm Dis 24:481-486.
Corey L., Five K.H., Benedetti J.K. (1983) Intravenous aciclovir for the treatment of primary genital herpes. Ann Intern Med 98:914-921.
Mindel A., Adler M.W., Sutherland S. (1982) Intravenous aciclovir treatment for primary genital herpes. Lancet 1:697-700.
Mindel A., Weller I.V., Faherty A. (1986) Aciclovir in first attacks of genital herpes and prevention of recurrences. Genitourin Med 62:28-32.
Goldberg L.H., Kaufman R., Conant M.A. (1986) Oral aciclovir for episodic treatment of recurrent genital herpes. J Am Acad Dermatol 15:256-264.
Reichman R.C., Badger G.J., Mertz G.J. (1984) Treatment of recurrent genital herpes simplex infections with oral aciclovir. JAMA 251:2103-2107.
Salo O.P., Lassus A., Hovi T. (1983) Double-blind placebo-controlled trial of oral aciclovir in recurrent genital herpes. Eur J Sex Transm Dis 1:95-98.
Engel J.P. (1998) Long-term suppression of genital herpes. JAMA 280:928-929.
Mattison H.R., Reichman R.C., Bolgiano J. (1988) Double-blind placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med 85:20-25.
Bodsworth N.J., Crooks R.J., Borelli S. (1997) Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: A randomised, double blind clinical trial. Genitourin Med , International valaciclovir study group; 73:110-116.
Spruance S.L., Tyring S.K., DeGregorio B. (1996) A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med , Valaciclovir HSV Study Group; 156:1729-1735.
Sacks S.L., Aoki F.Y., Diaz-Mitoma F. (1996) Patient-initiated, twice daily oral famciclovir for early recurrent genital herpes: A randomized, double blind multicenter trial. JAMA 276:44-49.
Kaplowitz L.G., Baker D., Gelb L. (1991) Prolonged continuous aciclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA 265:747-751.
Jefferson J.W. (1999) Antiviral therapies for long-term suppression of genital herpes. JAMA 281:1170-1171.
Mertz G.J., Clifton C.J., Mills J. (1988) Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: A multicenter double blind trial. JAMA 260:201-206.
Nikkels A.F., Pierard G.E. (2000) Factual approach to the treatment of genital herpes. Rev Med Liege 55:430-437.
Goldberg L.H., Kaufman R.H., Kurtz T.O. (1993) Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with aciclovir. J Med Virol 1:45-50.
Reitano M., Tyring S., Lang W. (1998) Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study. J Infect Dis 178:603-610.
Patel R., Bodsworth N.J., Woolley P. (1997) Valaciclovir for the suppression of recurrent genital HSV infection: A placebo-controlled study of once-daily therapy. Genitourin Med 73:105-109.
Diaz-Mitoma F., Sibbald R.G., Shafran S.D. (1998) Oral famciclovir for the suppression of recurrent genital herpes: A randomized controlled trial. JAMA 280:887-892.
Wald A., Corey L. (1999) Antiviral therapies for long-term suppression of genital herpes. JAMA 28:1169-1170.
Scoular A., Barton S. (1997) Therapy for genital herpes in immunocompromised patients: A national survey. Genitourin Med , The Herpes Simplex Advisory Panel; 73:391-393.
Andrei G., Fiten P., De Clercq E. (2001) Evaluating phenotype and genotype of drug-resistant strains in herpesviruses. Mol Biotechnol 18:155-167.
Andrei G., Snoeck R., De Clercq E. (1995) Susceptibilities of several drug-resistant herpes simplex virus type I strains to alternative antiviral compounds. Antimicrob Agents Chemother 39:1632-1635.
Wutzler P. (1997) Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology 40:343-356.
Leung D.T., Sacks S.L. (2000) Current recommendations for the treatment of genital herpes. Drugs 60:1329-1352.
White P.J., Garnett G.P. (1999) Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2. Sex Transm Infect 75:49-54.
Skinner G.R., Turyk M.E., Benson C.A. (1997) The efficacy and safety of skinner herpes simplex vaccine towards modulation of herpes genitalis: Report of a prospective double blind placebo-controlled trial. Med Microbiol Immunol 186:31-36.
Straus S.E., Corey L., Burke R.L. (1994) Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343:1460-1463.
Straus S.E., Wald A., Kost R.G. (1997) Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial. J Infect Dis 176:1129-1134.
Corey L., Langenberg A.G., Ashley R. (1999) Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials. JAMA , Chiron HSV Vaccine Study Group; 282:331-340.
Spruance S., Stanberry L.R. (2000) A prophylactic herpes simplex virus vaccine [oral presentation]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep 17; Salt Lake City (UT); .
Rompalo A.M., Mertz G.J., Davis L.G. (1988) Oral aciclovir for treatment of first-episode herpes simplex virus proctitis. JAMA 259:2879-2881.
Rosato F.E., Rosato E.F., Plotkin S.A. (1970) Herpetic paronychia an occupational hazard of medical personnel. N Eng J Med 283:804-805.
Gill M.J., Arlette J., Buchan K.A. (1988) Herpes simplex virus infection of the hand: A profile of 79 cases. Am J Med 84:89-93.
Gill M.J., Arlette J., Tyrrell L. (1988) Herpes simplex virus infection of the hand: Clinical features and management. Am J Med 85:53-56.
Herbert A.M., Bagg J., Walker D.M. (1995) Seroepidemiology of herpes virus infections among dental personnel. J Dent 23:339-342.
Gill M.J., Arlette J., Buchan K.A. (1990) Herpes simplex virus of the hand. J Am Acad Dermatol 23:111-116.
Snavely S.R., Liu C. (1984) Clinical spectrum of herpes simplex virus infections. Clin Dermatol 2:8-22.
Pechere M., Friedli A., Krischer J. (1999) Panaris multiples herpes simplex type 1. Ann Dermatol Venereol 126:646.
Gill M.J., Bryant H.E. (1991) Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand. Antimicrob Agents Chemother 35:382-383.
D'Andrea C.C., Ferrera P.C. (1998) Disseminated herpes simplex virus infection in a neonate. Am J Emerg Med 16:376-378.
Whitley R.J., Arvin A., Prober C. (1991) A controlled trial comparing vidarabine with aciclovir in neonatal herpes simplex infection. N Eng J Med 324:444-449.
Kimberlin D.W., Lin C.Y., Jacobs R.F. (2001) Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108:230-238.
Scott L.L., Sanchez P.J., Jackson G.L. (1996) Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 87:69-73.
Randolph A.G., Hartshorn R.M., Washington A.E. (1996) Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: A cost-effectiveness analysis. Obstet Gynecol 88:603-610.
Brocklehurst P., Kinghorn G., Carney O. (1998) A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 105:275-280.
Kimberlin D.F., Weller S., Whitley R.J. (1998) Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 179:846-851.
Scott L.L. (1999) Prevention of perinatal herpes: Prophylactic antiviral therapy?. Clin Obstet Gynecol 42:134-148.
Baker D.A. (1998) Antiviral therapy for genital herpes in nonpregnant and pregnant women. Int J Fertil Womens Med 43:243-248.
Euvrard S. (1998) Infectious cutaneous pathology after organ transplantation. Ann Dermatol Venereol 125:939-945.
Snoeck R., De Clercq E. (1995) Herpesvirus infections in immunocompromised patients. Cancer Treat Res 79:149-171.
Armstrong J.A., Evans A.S., Rao N. (1976) Viral infections in renal transplant recipients. Infect Immun 14:970-975.
Shlien R.D., Meyers S., Lee J.A. (1988) Fulminant herpes simplex hepatitis in a patient with ulcerative colitis. Gut 29:257-261.
Dehertogh D.A., Brettman L.R. (1988) Hemorrhagic cystitis due to herpes simplex virus as a marker of disseminated herpes infection. Am J Med 84:632-635.
Watts S.J., Alexander L.C., Fawcett K. (1986) Herpes simplex esophagitis in a renal transplant patient treated with cyclosporine A: A case report. Am J Gastroenterol 81:185-188.
Rand K.H., Kramer B., Johnson A.C. (1982) Cancer chemotherapy associated stomatitis: Role of herpes simplex virus (HSV). Cancer 50:1262-1265.
Nikkels A.F., Delvenne P., Sadzot-Delvaux C. (1996) Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol 49:243-248.
Gabel H., Flamholc L., Ahlfors K. (1988) Herpes simplex virus hepatitis in a renal transplant recipient: Successful treatment with acyclovir. Scand J Infect Dis 20:435-438.
Skoldenberg B., Forsgren M., Alestig K. (1984) Acyclovir versus vidarabine in herpes simplex encephalitis: Randomised multicentre study in consecutive Swedish patients. Lancet 2:707-711.
Whitley R.J., Alford C.A., Hirsch M.S. (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314:144-149.
Koutsky L.A., Stevens C.E., Holmes K.K. (1992) Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 326:1533-1539.
Nikkels A.F., Sadzot-Delvaux C., Rentier B. (1998) Low-productive alpha-herpesviridae infection in chronic lichenoid dermatoses. Dermatology 196:442-446.
Nikkels A.F., Pierard G.E. (1999) Chronic herpes simplex virus type I glossitis in an immunocompromised man. Br J Dermatol 140:343-346.
Nikkels A.F., Debrus S., Sadzot-Delvaux C. (1993) Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Archiv A Pathol Anat 422:121-126.
Marsella R.C., Buckner S.B., Bratthauer G.L. (1995) Identification of genital herpes simplex virus infection by immunoperoxidase staining. Appl Immunohistochem 3:184-189.
Ustacelebi S. (2001) Diagnosis of herpes simplex virus infections. J Clin Virol 21:255-259.
Rudlinger R., Norval M. (1989) Herpes simplex virus infections: New concepts in an old disease. Dermatologica 178:1-5.
Taylor J.R., Schmieder G.J., Shimizu T. (1994) Interrelationship between ultraviolet light and recurrent herpes simplex infections in man. J Dermatol Sci 8:224-232.
Spruance S.L. (1985) Pathogenesis of herpes simplex labialis, experimental induction with UV light. J Clin Microbiol 22:366-368.
Blyth W., Hill T.J., Field H.J. (1976) Reactivation of herpes simplex infection by ultraviolet light and possible involvement of aglandins. J Gen Virol 33:547-550.
Spruance S.L., Freeman D.J., Stewart J.C. (1991) The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J infect Dis 163:728-734.
Boon R., Goodman J.J., Martinez J. (2000) Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: A randomized, double-blind, placebo-controlled trial. Clin Ther 22:76-90.
Foley F.D., Greenwald K.A., Nash G. (1970) Herpes virus infection in burned patients. N Engl J Med 282:652-656.
Bourdarias B., Perro G., Cutillas M. (1996) Herpes simplex virus infection in burned patients: Epidemiology of 11 cases. Burns 22:287-290.
Brandt S.J., Tribble C.G., Lakeman A.D. (1985) Herpes simplex burn wounds infections: Epidemiology of a case cluster and responses to acyclovir therapy. Surgery 98:338-343.
Ptak J.J., Stein J.M. (1984) Treatment of herpes simplex viral burn wound infection with topical acyclovir. J Burn Care Rehabil 5:171-173.
Goodyear H.M., McLeish P., Randall S. (1996) Immunological studies of herpes simplex virus infection in children with atopic eczema. Br J Dermatol 134:85-93.
Niimura M., Nishikawa T. (1988) Treatment of eczema herpeticum with oral aciclovir. Am J Med 85:49-52.
Brown P., Taylor B. (1989) Herpes simplex infection associated with pemphigus vulgaris: Case report and literature review. J Am Acad Dermatol 21:1126-1128.
Hale E.K., Bystryn J.C. (1999) Atypical herpes simplex can mimic a flare of disease activity in patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol 13:221-223.
Tufano M.A., Baroni A., Buommino E. (1999) Detection of herpesvirus DNA in peripheral blood mononuclear cells and skin lesions of patients with pemphigus by polymerase chain reaction. Br J Dermatol 141:1033-1039.
Flint I.D., Spencer D.M., Wilkin J.K. (1993) Eczema herpeticum in association with familial benign chronic pemphigus. J Am Acad Dermatol 28:257-259.
Takahashi I., Kobayashi T.K., Suzuki H. (1998) Coexistence of Pemphigus vulgaris and herpes simplex virus infection in oral mucosa diagnosed by cytology, immunohistochemistry, and polymerase chain reaction. Diagn Cytopathol 19:446-450.
Schlupen E.M., Wollenberg A., Hanel S. (1996) Detection of herpes simplex virus in exacerbated pemphigus vulgaris by polymerase chain reaction. Dermatology 192:312-316.
Palleschi G.M., Falcos D., Giacomelli A. (1996) Kaposi's varicelliform eruption in pemphigus foliaceus. Int J Dermatol 35:809-810.
Parslew R., Verbov J.L. (1994) Kaposi's varicelliform eruption due to herpes simplex in Darier's disease. Clin Exp Dermatol 19:428-429.
Hur W., Lee W.S., Ahn S.K. (1994) Acral Darier's disease: Report of a case complicated by Kaposi's varicelliform eruption. J Am Acad Dermatol 30:860-862.
Hill T.J., Blyth W.A., Harbour D.A. (1978) Trauma to the skin causes recurrence of herpes simplex in the mouse. J Gen Virol 39:21-28.
Belongia E.A., Goodman J.L., Holland E.J. (1991) An outbreak of herpes gladiatorum at a high-school wrestling camp. N Engl J Med 325:906-910.
Becker T.M., Kodsi R., Bailey P. (1988) Grappling with herpes: Herpes gladiatorum. Am J Sports Med 16:665-669.
Holland E.J., Mahanti R.L., Belongia E.A. (1992) Ocular involvement in an outbreak of herpes gladiatorum. Am J Ophthalmol 114:680-684.
Becker T.M. (1992) Herpes gladiatorum: A growing problem in sports medicine. Cutis 50:150-152.
Mare J.B., Keyzer C.M., Becker W.B. (1978) Traumatic Herpes hominis infection during rugby (Herpes venatorum): A discussion of four cases. South Afr Med J 54:752-754.
Kameyama T., Futami M., Nakayoshi N. (1989) Shedding of herpes simplex virus type 1 into saliva in patients with orofacial fracture. J Med Virol 28:78-80.
Fitzpatrick R.E., Goldman M.P., Satur N.M. (1996) Pulsed carbon dioxide laser resurfacing of photoaged facial skin. Arch Dermatol 132:395-402.
Fulton J.E. (1997) Complications of laser resurfacing. Dermatol Surg 24:91-99.
Roberts T.L., Weinstein C., Alexandides J.K. (1997) Aesthetic CO2 laser surgery: Evaluation of 907 patients. Aesth Surg J 17:293-303.
Waldorf H.A., Kauvar A.N.B., Geronemus R.G. (1995) Skin resurfacing of fine to deep rhytides using a char-free carbon dioxide laser in 47 patients. Dermatol Surg 21:940-946.
Roberts T.L., Lettieri J.T., Ellis K.B. (1996) CO2 laser resurfacing: Recognizing and minimizing complications. Aesth Surg Quart 16:142-148.
Nanni C.A. (1997) Complications of laser surgery. Dermatol Clin 15:521-534.
Silverman A.K., Laing K.F., Swanson N.A. (1985) Activation of herpes simplex following dermabrasion. J Am Acad Dermatol 13:103-108.
Monheit G.D. (1995) Facial resurfacing may trigger the herpes simplex virus. Cosmet Dermatol 8:9-16.
Perkin S.W., Sklarew E.C. (1996) Prevention of facial herpes after chemical peel and dermabrasion: New treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area. Plast Reconstr Surg 98:427-433.
Ratner D., Tse Y., Marchell N. (1999) Cutaneous laser resurfacing. J Am Acad Dermatol 41:365-389.
Weinstein C., Ramirez O., Pozner J. (1998) Postoperative care following carbon dioxide laser resurfacing. Dermatol Surg 24:51-56.
Wall S.H., Ramey S.J., Wall F. (1999) Famciclovir as antiviral prophylaxis in laser resurfacing procedures. Plast Reconstr Surg 104:1103-1108.
Alster T.S., Nanni C.A. (1999) Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg 25:242-246.
Pazin G.J., Ho M., Jannetta P.J. (1978) Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis 138:405-409.
Carton C.A. (1953) Effect of previous sensory loss on the appearance of herpes simplex following trigeminal sensory root section. J Neurosurg 10:463-468.
Nabors M.W., Francis C.K., Kobrine A.I. (1986) Reactivation of herpesvirus in neurosurgical patients. Neurosurgery 19:599-603.
Pazin G.T., Armstrong J.A., Lain M.T. (1987) Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med 301:225-230.
Crone L.A., Conly J.M., Clark K.M. (1988) Recurrent herpes simplex virus labialis and the use of epidural morphine in obstetric patients. Anesth Analg 67:318-323.
Crone L.A., Conly J.M., Storgard C. (1990) Herpes labialis in parturients receiving epidural morphine following cesarean section. Anesthesiology 73:208-213.
Boyle R.K. (1995) Herpes simplex labialis after epidural or parenteral morphine: A randomized prospective trial in an Australian obstetric population. Anaesth Intensive Care 23:433-437.
Hanley P.J., Conaway M.M., Halstead D.C. (1993) Nosocomial herpes simplex virus infection associated with oral endotracheal intubation. Am J Infect Control 6:310-316.
Openshaw H., Sekizawa T., Cantin E. (1982) Latency and reactivation of herpes simplex virus. Viral infections in oral medicine , Hook J. Jordan JW, editors. New York: Elsevier/North-Holland; 79-88.
Openshaw H., Bennet H.E. (1982) Recurrence of herpes simplex virus after dental extraction. J Infect Dis 46:70.
Kennedy C.T.C., Leigh I.M., Ridgway H.A. (1981) Treatment of erythema multiforme secondary to herpes simplex by prophylactic topical aciclovir. BMJ 283:1360-1361.
Tatnall F.M., Schofield J.K., Leigh I.M. (1995) A double blind placebo-controlled trial of continuous ACV therapy in recurrent erythema multiforme. Br J Dermatol 132:267-270.
Huff J.C. (1988) Aciclovir for recurrent erythema multiforme caused by herpes simplex. J Am Acad Dermatol 18:197-199.
Huff J.C. (1988) Therapy and prevention of erythema multiforme with aciclovir. Semin Dermatol 7:212-217.
Goldberg L.H., Sperber J. (1986) Erythema multiforme due to herpes simplex: Treatment with oral aciclovir. South Med J 79:757-759.
Lemak M.A., Duvic M., Bean S.F. (1986) Oral aciclovir for the prevention of herpes associated ema multiforme. J Am Acad Dermatol 15:50-54.